New director of Global Healthcare and Brand Advocacy at Ketchum

Ketchum has hired Ann Moravick as executive vice-president and director of global healthcare and brand advocacy.

Effective from 4 September 2007, Moravick will lead the expanding global reach of the agency's Healthcare Practice by bridging the work of its international offices. She also will lead a new approach to brand building through product and service development which blends traditional and non-traditional marketing tools to create brand awareness and passionate advocates for healthcare clients.

Moravick will be based in New York and report to partners Dale Bornstein, director, global practices, and Barri Rafferty, director, New York. She will work closely with Ketchum's global healthcare team leaders to continue to strengthen its collaborative network and will be responsible for the practice's strategic direction, business development and acquisition of talent.

In Moravick's previous roles, she counselled clients on communications challenges ranging from international global strategy, organisational and product positioning, brand marketing, issues and crisis management and corporate philanthropy.

Most recently, she served as the US CEO of Publicis Consultants PR. Prior to joining Publicis, Moravick spent 18 years at Manning, Selvage & Lee, where she held a number of key positions, including managing director of the firm's London office, deputy managing director of the New York office and managing director of the firm's global healthcare practice.

Moravick has worked with a wide range of clients, including some of the industry's largest pharmaceutical companies, professional services firms, and industry bodies. Among her past clients are Johnson & Johnson, Roche, sanofi-aventis, Novartis, Pfizer, Eli Lilly & Company and Procter & Gamble.

Moravick is co-chair of the healthcare committee of the Word of Mouth Marketing Association (WOMMA) and a former board member of the organisation.